(Total Views: 461)
Posted On: 11/23/2025 3:26:49 PM
Post# of 158771
Targeting WEE1 Kinase for Breast Cancer Therapeutic: An Update.
In summary, there is no need to identify Novel Therapeutic to TNBC treatment, and WEE1 has emerged as a candidate.
DOD breakthrough Breast Cancer Research Program Grant Awards.
Dr. Richard G. Pestell, our lead consultant here at Cytodyn has been busy in the following areas;
(1) Conceptualization
(2) Final draft preparation
(3) final review and editing
(4) Supervision
(5) Project administration
(6) Funding Acquistion
Dr. Pestell has 3 times plus, more Citations than the 17 other Authors
"Interestingly,....... Leronlimab and immune check point inhibitor,
were alive (>48 months)"...now there, is the BOMB.
In summary, there is no need to identify Novel Therapeutic to TNBC treatment, and WEE1 has emerged as a candidate.
DOD breakthrough Breast Cancer Research Program Grant Awards.
Dr. Richard G. Pestell, our lead consultant here at Cytodyn has been busy in the following areas;
(1) Conceptualization
(2) Final draft preparation
(3) final review and editing
(4) Supervision
(5) Project administration
(6) Funding Acquistion
Dr. Pestell has 3 times plus, more Citations than the 17 other Authors
"Interestingly,....... Leronlimab and immune check point inhibitor,
were alive (>48 months)"...now there, is the BOMB.
(5)
(0)
